NGOZI OBIORA: Open Payments
NPI 1417918939 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,641 in 190 payments from 13 companies in 2025. Trend: 2023 $4,374 · 2024 $4,662 · 2025 $5,641
Food & beverage: $5,577Education: $65
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 26 | $1,051 |
| Otsuka America Pharmaceutical, Inc. | 20 | $645 |
| Neurocrine BioSciences, Inc. | 28 | $608 |
| Axsome Therapeutics, Inc. | 19 | $577 |
| Janssen Pharmaceuticals, Inc | 22 | $534 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $513 |
| Alkermes, Inc. | 12 | $438 |
| Vanda Pharmaceuticals Inc. | 21 | $420 |
| Lundbeck LLC | 17 | $416 |
| ABBVIE INC. | 10 | $339 |
Products named: REXULTI, INGREZZA, Auvelity, AUSTEDO XR, CAPLYTA, UZEDY, INVEGA SUSTENNA, FANAPT.
Industry payments across WI — which companies pay providers there.
